Cases & Deals

Celgene enforces its Revlimid® patents against Zydus Pharmaceuticals under Hatch-Waxman Act

Clients Celgene Corporation

Jones Day is representing Celgene Corporation in a patent litigation against Zydus Pharmaceuticals and Cadila Healthcare over Revlimid®, Celgene's blockbuster drug for treating multiple myeloma and other cancers.

Celgene Corp. v. Zydus Pharmaceuticals (USA) Inc., et al., No. 2-17-cv-02528 (D.N.J.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.